Laporan Laba Rugi AMPH - TTM - Amphastar Pharmaceuticals, Inc.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Amphastar Pharmaceuticals, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	337	350	368	384	413	438	455	477	485	499	519	541	601	644	676	713	724	732	731	723
Change (%)		3.72	5.24	4.31	7.49	6.05	3.96	4.79	1.66	2.92	3.94	4.29	11.17	7.16	4.94	5.42	1.50	1.16	-0.18	-1.09
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	197	207	217	218	232	238	244	250	251	250	249	265	272	291	309	320	340	358	362	362
Change (%)		4.60	4.94	0.77	6.45	2.39	2.72	2.38	0.24	-0.32	-0.42	6.25	2.96	6.65	6.28	3.74	6.19	5.26	0.99	0.19
% of Revenue	58.53	59.03	58.86	56.86	56.31	54.37	53.72	52.49	51.75	50.13	48.02	48.93	45.31	45.09	45.67	44.94	47.02	48.92	49.50	50.14

Gross Operating Profit	140	143	151	166	180	200	211	227	234	249	270	276	329	354	367	393	383	374	369	360
Change (%)		2.47	5.67	9.37	8.86	10.76	5.45	7.59	3.23	6.38	8.32	2.48	19.04	7.59	3.83	6.84	-2.33	-2.48	-1.30	-2.35
% of Revenue	41.47	40.97	41.14	43.14	43.69	45.63	46.28	47.51	48.25	49.87	51.98	51.07	54.69	54.91	54.33	55.06	52.98	51.08	50.50	49.86

SG&A	63	63	69	67	68	67	65	62	63	67	69	72	75	80	85	88	93	95	97	99
Change (%)		-0.73	9.28	-1.83	0.46	-0.92	-2.81	-4.54	1.79	5.05	3.91	4.72	3.16	7.55	5.54	3.89	5.39	1.74	2.98	1.98
% of Revenue	18.77	17.97	18.66	17.56	16.41	15.33	14.33	13.06	13.07	13.35	13.34	13.40	12.43	12.48	12.55	12.36	12.84	12.91	13.32	13.74

R&D	69	67	67	69	62	61	62	67	75	75	78	72	71	74	71	72	76	74	77	79
Change (%)		-2.20	-0.80	2.96	-10.03	-1.37	2.39	7.49	11.56	-0.07	4.80	-7.60	-2.55	4.51	-3.76	1.14	6.15	-2.99	4.13	3.15
% of Revenue	20.38	19.22	18.11	17.88	14.97	13.92	13.71	14.06	15.43	14.98	15.11	13.39	11.73	11.44	10.50	10.07	10.53	10.10	10.53	10.99

OpEx	329	337	352	354	362	366	372	380	389	391	397	409	418	445	465	480	509	527	536	541
Change (%)		2.16	4.61	0.67	2.12	1.13	1.65	2.03	2.49	0.61	1.31	3.25	2.02	6.45	4.48	3.37	6.04	3.39	1.79	0.94
% of Revenue	97.68	96.21	95.63	92.30	87.69	83.62	81.76	79.61	80.26	78.46	76.47	75.71	69.48	69.01	68.71	67.37	70.39	71.94	73.35	74.86

Operating Income	8	13	16	30	51	72	83	97	96	107	122	131	184	200	212	233	214	205	195	182
Change (%)		69.25	21.32	83.84	71.89	41.08	15.77	17.19	-1.58	12.31	13.51	7.68	39.69	8.80	5.95	9.94	-7.88	-4.12	-5.22	-6.69
% of Revenue	2.32	3.79	4.37	7.70	12.31	16.38	18.24	20.39	19.74	21.54	23.53	24.29	30.52	30.99	31.29	32.63	29.61	28.06	26.65	25.14

Interest Expense	-0	-0	-0	-0	-1	-1	-1			-2	-2	-11	-21	-33	-36	-38	-38	-35	-41	-32
Change (%)		13.68	7.49	12.69	77.70	9.94	28.36				2.33	492.59	91.44	54.26	9.11	6.12	-1.58	-6.19	16.34	-22.44
% of Revenue	-0.10	-0.11	-0.11	-0.12	-0.20	-0.20	-0.25			-0.37	-0.36	-2.07	-3.56	-5.13	-5.33	-5.37	-5.21	-4.83	-5.63	-4.41

Net Income	7	1	2	10	36	62	81	91	77	91	93	102	135	138	155	167	158	160	142	135
Change (%)		-78.90	77.83	319.00	245.16	72.15	30.93	11.78	-15.04	18.33	1.95	9.42	32.71	1.67	12.47	7.64	-5.28	1.14	-11.22	-4.89
% of Revenue	1.97	0.40	0.68	2.72	8.74	14.19	17.87	19.06	15.93	18.31	17.96	18.85	22.50	21.34	22.88	23.36	21.80	21.79	19.38	18.64

Source: Capital IQ

Amphastar Pharmaceuticals, Inc. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings